These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 8426573)

  • 1. Renal toxicity and chemotherapy in children with cancer.
    Ruggiero A; Ferrara P; Attinà G; Rizzo D; Riccardi R
    Br J Clin Pharmacol; 2017 Dec; 83(12):2605-2614. PubMed ID: 28758697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and Risk Factors of Hypomagnesemia in Head and Neck Cancer Patients Treated with Cetuximab.
    Enokida T; Suzuki S; Wakasugi T; Yamazaki T; Okano S; Tahara M
    Front Oncol; 2016; 6():196. PubMed ID: 27683640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-related nephrotoxicity of carboplatin in children.
    English MW; Skinner R; Pearson AD; Price L; Wyllie R; Craft AW
    Br J Cancer; 1999 Sep; 81(2):336-41. PubMed ID: 10496362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central nervous system disease in Langerhans cell histiocytosis.
    Grois N; Tsunematsu Y; Barkovich AJ; Favara BE
    Br J Cancer Suppl; 1994 Sep; 23():S24-8. PubMed ID: 8075002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Langerhans cell histiocytosis--clinical and epidemiological aspects.
    Broadbent V; Egeler RM; Nesbit ME
    Br J Cancer Suppl; 1994 Sep; 23():S11-6. PubMed ID: 8075001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The kidney in children under chemotherapy].
    Cachat F; Guignard JP
    Rev Med Suisse Romande; 1996 Dec; 116(12):985-93. PubMed ID: 9026889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent nephrotoxicity during 10-year follow-up after cisplatin or carboplatin treatment in childhood: relevance of age and dose as risk factors.
    Skinner R; Parry A; Price L; Cole M; Craft AW; Pearson AD
    Eur J Cancer; 2009 Dec; 45(18):3213-9. PubMed ID: 19850470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carboplatin pharmacokinetics in children: the development of a pediatric dosing formula. The United Kingdom Children's Cancer Study Group.
    Newell DR; Pearson AD; Balmanno K; Price L; Wyllie RA; Keir M; Calvert AH; Lewis IJ; Pinkerton CR; Stevens MC
    J Clin Oncol; 1993 Dec; 11(12):2314-23. PubMed ID: 8246021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GLOMERULAR FILTRATION RATE PROFILES IN PAEDIATRIC PATIENTS ON CANCER CHEMOTHERAPY AT THE KENYATTA NATIONAL HOSPITAL, KENYA.
    Mburu M; Wamalwa D; Bashir A; Wainaina L
    East Afr Med J; 2012 Feb; 89(2):45-52. PubMed ID: 26845811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimation of renal function and its potential impact on carboplatin dosing in children with cancer.
    Chinnaswamy G; Cole M; Boddy AV; Keir M; Price L; Parry A; English M; Veal GJ;
    Br J Cancer; 2008 Sep; 99(6):894-9. PubMed ID: 18781149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nephrotoxicity following carboplatin use in children: is routine monitoring of renal function necessary?
    Brandt LJ; Broadbent V
    Med Pediatr Oncol; 1993; 21(1):31-5. PubMed ID: 8426573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early and late renal adverse effects after potentially nephrotoxic treatment for childhood cancer.
    Knijnenburg SL; Mulder RL; Schouten-Van Meeteren AY; Bökenkamp A; Blufpand H; van Dulmen-den Broeder E; Veening MA; Kremer LC; Jaspers MW
    Cochrane Database Syst Rev; 2013 Oct; (10):CD008944. PubMed ID: 24101439
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.